Pregnancy in cancer patients and survivors

Oncofertility Medical Practice: Clinical Issues and Implementation

Volumn , Issue , 2012, Pages 129-148

  Wang, Eileen ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84899436254     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4419-9425-7_10     Document Type: Chapter

References (49)

1. Gordon MC. Maternal physiology. In: Gabbe SG et al., editors. Obstetrics: normal and problem pregnancies. 5th ed. Philadelphia: Churchill Livingstone; 2007.
2. Kametas NA, et al. Maternal cardiac function in twin pregnancy. Obstet Gynecol. 2003;102:806-15.
3. Hudson MM. Survivors of childhood cancer: coming of age. Hematol Oncol Clin North Am. 2008;22:211-31.
4. Van Dalen EC, et al. Clinical heart failure during pregnancy and delivery in a cohort of female childhood cancer survivors treated with anthracyclines. Eur J Cancer. 2006;42:2549-53.
5. Carver JR, et al. American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects. J Clin Oncol. 2007;25:3991-4008.
6. Bar J. Pregnancy outcome in women treated with doxorubicin for childhood cancer. Am J Obstet Gynecol. 2003;189:853-7.
7. Ng AK, LaCasce A, Travis LB. Long-term complications of lymphoma and its treatment. J Clin Oncol. 2011;29:1885-92.
8. Ng A, et al. ACR appropriateness criteria: follow-up of Hodgkin lymphoma. Curr Probl Cancer. 2010;34:211-27.
9. Yahalom J, Portlock CS. Long-term cardiac and pulmonary complications of cancer therapy. Hematol Oncol Clin North Am. 2008;22:305-18.
10. Skinner R, et al. Persistent nephrotoxicity during 10-year follow-up after cisplatin or carbopla-tin treatment in childhood: releVance of age and dose as risk factors. Eur J Cancer. 2009;45:3213-9.
11. Skinner R, Cotterill SJ, Stevens MCG. Risk factors for nephrotoxicity after ifosfamide treatment in children: a UKCCSG Late Effects Group study. Br J Cancer. 2000;82:1636-45.
12. Holm K, et al. Ultrasound B-mode changes in the uterus and ovaries and Doppler changes in the uterus after total body irradiation and allogeneic bone marrow transplantation in childhood. Bone Marrow Transplant. 1999;23:259-63.
13. Armenian SH, Bhatia S. Chronic health conditions in childhood cancer survivors: is it all treatment-related-or do genetics play a role? J Gen Intern Med. 2009;24:395-400.
14. Sklar CA, et al. Changes in body mass index and prevalence of overweight in survivors of childhood acute lymphoblastic leukemia: role of cranial irradiation. Med Pediatr Oncol. 2000;35:91-5.
15. Travis LB, et al. Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. JAMA. 2003;290:465-75.
16. Ruhl C, Moran B. The clinical content of preconception care: preconception care for special populations. Am J Obstet Gynecol. 2008;199:S384-8.
17. Blatt J. Pregnancy outcome in long-term survivors of childhood cancer. Med Pediatr Oncol. 1999;33:29-33.
18. Signorello LB, et al. Female survivors of childhood cancer: preterm birth and low birth weight among their children. J Natl Cancer Inst. 2006;98:1453-61.
19. Green DM, et al. Pregnancy outcome after treatment for Wilms tumor: a report from the National Wilms Tumor Long-Term Follow-Up Study. J Clin Oncol. 2010;28:2824-30.
20. Khatcheressian JL, et al. American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuVant setting. J Clin Oncol. 2006;24:5091-7.
21. Brusamolino E, et al. Classical Hodgkin’s lymphoma in adults: guidelines of the Italian Society of Hematology, the Italian Society of Experimental Hematology, and the Italian Group for Bone Marrow Transplantation on initial work-up, management, and follow-up. Haematologica. 2009;94:550-65.
22. Pereg D, Koren G, Lishner M. The treatment of Hodgkin’s and non-Hodgkin’s lymphoma in pregnancy. Haematologica. 2007;92:1230-7.
23. Smith LH, et al. Obstetrical deliveries associated with maternal malignancy in California, 1992 through 1997. Am J Obstet Gynecol. 2001;184:1504-12, 1512-1513 Discussion.
24. Pettersson BF, et al. Invasive carcinoma of the uterine cervix associated with pregnancy. Cancer. 2010;116:2343-9.
25. ACOG Committee Opinion. Guidelines for diagnostic imaging during pregnancy. Number 299, September 2004 (replaces No. 158, September 1995). Obstet Gynecol. 2004;104:647-51.
26. Voulgaris E, Pentheroudakis G, Pavlidis N. Cancer and pregnancy: a comprehensive review. Surg Oncol. 2011;20:e175-85.
27. Doll DC, Ringenberg QS, Yarbro JW. Antineoplastic agents and pregnancy. Semin Oncol. 1989;16:337-46.
28. Cardonick E, Iacobucci A. Use of chemotherapy during human pregnancy. Lancet Oncol. 2004;5:283-91.
29. Kal HB, Struikmans H. Radiotherapy during pregnancy: fact and fiction. Lancet Oncol. 2005;6:328-33.
30. Alexander A, et al. Metastatic melanoma in pregnancy: risk of transplacental metastases in the infant. J Clin Oncol. 2003;21:2179-86.
31. Aviles A, Neri N. Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero. Clin Lymphoma. 2001;2:173-7.
32. Germann N, Goffinet F, Goldwasser F. Anthracyclines during pregnancy: embryo-fetal outcome in 160 patients. Ann Oncol. 2004;15:146-50.
33. Aviles A, Neri N, Nambo MJ. Long-term evaluation of cardiac function in children who received anthracyclines during pregnancy. Ann Oncol. 2006;17:286-8.
34. Meyer-Wittkopf M, et al. Fetal cardiac effects of doxorubicin therapy for carcinoma of the breast during pregnancy: case report and review of the literature. Ultrasound Obstet Gynecol. 2001;18:62-6.
35. Litton JK, Theriault RL, Gonzalez-Angulo AM. Breast cancer diagnosis during pregnancy. Womens Health. 2009;5:243-9.
36. Leslie KK, Lange CA. Breast cancer and pregnancy. Obstet Gynecol Clin North Am. 2005;32:547-58.
37. Nettleton J, et al. Breast cancer during pregnancy: quantifying the risk of treatment delay. Obstet Gynecol. 1996;87:414-8.
38. Cardonick E, et al. Breast cancer during pregnancy. Cancer J. 2010;16:76-82.
39. Hahn KME, et al. Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero. Cancer. 2006;107:1219-26.
40. Litton JK, Theriault RL. Breast cancer and pregnancy: current concepts in diagnosis and treatment. Oncologist. 2010;15:1238-47.
41. Amant F, et al. Breast cancer in pregnancy: recommendations of an international consensus meeting. Eur J Cancer. 2010;46:3158-68.
42. Mir O, et al. Taxanes for breast cancer during pregnancy: a systematic review. Ann Oncol. 2010;21:425-6.
43. Pereg D, Koren G, Lishner M. Cancer in pregnancy: gaps, challenges and solutions. Cancer Treat Rev. 2008;34:302-12.
44. Dalberg K, Eriksson J, Holmberg L. Birth outcome in women with previously treated breast cancer-a population-based cohort study from Sweden. PLoS Med. 2006;3:1597-601.
45. Hurley TJ, McKinnell JV, Irani MS. Hematologic malignancies in pregnancy. Obstet Gynecol Clin North Am. 2005;32:595-614.
46. Woo SY, et al. Radiotherapy during pregnancy for clinical stages IA-IIA Hodgkin’s disease. Int J Radiat Oncol Biol Phys. 1992;23:407-12.
47. Oduncu FS, et al. Cancer in pregnancy: maternal-fetal conflict. J Cancer Res Clin Oncol. 2003;129:133-46.
48. Barber HRK. Malignant disease in pregnancy. J Perinat Med. 2001;29:97-111.
49. Schwartz N, Timor-Tritsch IE, Wang E. Adnexal masses in pregnancy. Clin Obstet Gynecol. 2009;52:570-85.